Neuberger Berman Group
RYTM icon

Neuberger Berman Group’s Rhythm Pharmaceuticals RYTM Stock Holding History

Neuberger Berman Group’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.22M Buy
83,035
+9,601
+13% +$868K 0.01% 899
2026
Q1 		$6.39M Sell
73,434
-138
-0.2% -$13.4K ﹤0.01% 932
2025
Q4 		$7.88M Sell
73,572
-11,545
-14% -$1.22M 0.01% 861
2025
Q3 		$8.6M Sell
85,117
-1,022
-1% -$94.9K 0.01% 837
2025
Q2 		$5.44M Buy
86,139
+18,200
+27% +$1.11M ﹤0.01% 943
2025
Q1 		$3.6M Buy
+67,939
New +$3.77M ﹤0.01% 997

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Neuberger Berman Group's RYTM Position: Q2 2026 in Review

Neuberger Berman Group increased its Rhythm Pharmaceuticals (RYTM) stake by 13% in Q2 2026, buying an estimated $868K and bringing the position to 83,035 shares worth $9.22M. The position accounts for 0.01% of the portfolio, ranked #899.

Neuberger Berman Group first reported a position in RYTM in Q1 2025 and has held it in 6 quarters since. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Neuberger Berman Group held 83,035 shares of Rhythm Pharmaceuticals worth $9.22M as of Q2 2026.
  • Neuberger Berman Group bought 9,601 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $868K.
  • Rhythm Pharmaceuticals made up 0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #899 holding.
  • Neuberger Berman Group first reported a position in Rhythm Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.